AstraZenec

U.S. stocks rose as investors felt that earnings season is positive enough so far to reverse weakness the markets have seen in recent weeks. "Investors were braced for poor results, and at least so far, the numbers have been better than feared. We'll have a little more information to act on...

Wednesday marked another day of mixed trading as investors and traders continue to find little clarity from the quarterly results released so far. With the markets being a "mixed bag" major indices ended the day little changed with the Dow ending slightly in the red and both S&P 500 and...